Proposed Data Collection Submitted for Public Comment and Recommendations, 42503-42505 [2018-18053]
Download as PDF
<![CDATA[
42503
Federal Register / Vol. 83, No. 163 / Wednesday, August 22, 2018 / Notices
Background and Brief Description
The Centers for Disease Control and
Prevention’s (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Division of Global
Migration and Quarantine (DGMQ),
Immigrant, Refugee, and Migrant Health
Branch (IRMH), requests approval for a
revision of an existing information
collection. This project pertains to
collecting annual reports on certain
tuberculosis data from U.S. panel
physicians.
The respondents are panel physicians.
More than 760 panel physicians from
336 panel sites perform overseas predeparture medical examinations in
accordance with requirements, referred
to as technical instructions, provided by
DGMQs Quality Assessment Program
(QAP). The role of QAP is to assist and
guide panel physicians in the
implementation of the Technical
Instructions; evaluate the quality of the
overseas medical examination for U.S.bound immigrants and refugees; assess
potential panel physician sites; and
provide recommendations to the U.S.
Department of State in matters of
immigrant medical screening.
To achieve DGMQ’s mission, the
Immigrant, Refugee and Migrant Health
these classifications to report new
immigrant and refugee arrivals with a
higher risk of developing TB disease to
U.S. state and local health departments
for further follow-up. Some information
that panel physicians collect as part of
the medical exam is not reported on the
standard Department of State forms (DSforms), thereby preventing CDC from
evaluating TB trends in globally mobile
populations and monitoring program
effectiveness.
Currently, CDC is requesting this data
be sent by panel physicians once per
year. The consequences of reducing this
frequency would be the loss of
monitoring program impact and TB
burdens in mobile populations and
immigrants and refugees coming to the
United States on an annual basis. The
total hours requested is 1,008. There is
no cost to the respondents other than
their time.
Estimated annual burden is being
reduced by 1,640 hours per year. The
number of respondents is being reduced
by 17. Reductions are due to revised
estimates on burden time per response,
and the removal of four variables from
the data collection form and improved
IT capacity at most panel sites.
branch (IRMH) works with domestic
and international programs to improve
the health of U.S.-bound immigrants
and refugees to protect the U.S. public
by preventing the importation of
infectious disease. These goals are
accomplished through IRMH’s oversight
of medical exams required for all U.S.bound immigrants and refugees who
seek permanent residence in the U.S.
IRMH is responsible for assisting and
training the international panel
physicians with the implementation of
medical exam Technical Instructions
(TI). Technical Instructions are detailed
requirements and national policies
regarding the medical screening and
treatment of all U.S.-bound immigrants
and refugees.
Screening for tuberculosis (TB) is a
particularly important component of the
immigration medical exam and allows
panel physicians to diagnose active TB
disease prior to arrival in the United
States. As part of the Technical
Instructions requirements, panel
physicians perform chest x-rays and
laboratory tests that aid in the
identification of tuberculosis infection
(Class B1 applicants) and diagnosis of
active tuberculosis disease (Class A,
inadmissible applicants). CDC uses
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
(in hours)
Form name
International panel physicians ..........
TB Indicators Excel Spreadsheet ....
336
1
3
1,008
Total ...........................................
...........................................................
........................
........................
........................
1,008
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–18054 Filed 8–21–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
amozie on DSK3GDR082PROD with NOTICES1
Number of
respondents
Type of respondents
[60Day–18–0338; Docket No. CDC–2018–
0076]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
VerDate Sep<11>2014
16:34 Aug 21, 2018
Jkt 244001
Notice with comment period
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed work and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a continuing information
collection project titled Annual
Submission of the Ingredients Added to,
and the Quantity of Nicotine Contained
in, Smokeless Tobacco Manufactured,
Imported, or Packaged in the U.S.
SUMMARY:
CDC must receive written
comments on or before October 22,
2018.
DATES:
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS)
AGENCY:
ACTION:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
You may submit comments,
identified by Docket No. CDC–2018–
0076 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
ADDRESSES:
E:\FR\FM\22AUN1.SGM
22AUN1
42504
Federal Register / Vol. 83, No. 163 / Wednesday, August 22, 2018 / Notices
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act
of 1995 (PRA) (44 U.S.C. 3501–3520),
Federal agencies must obtain approval
from the Office of Management and
Budget (OMB) for each collection of
information they conduct or sponsor. In
addition, the PRA also requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each new proposed
collection, each proposed extension of
existing collection of information, and
each reinstatement of previously
approved information collection before
submitting the collection to the OMB for
approval. To comply with this
requirement, we are publishing this
notice of a proposed data collection as
described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
Service (CAS) Registration Number,
consistent with accepted reporting
practices for other companies that are
required to report ingredients added to
other consumer products. Typically,
respondents submit a summary report to
CDC with the ingredient information for
multiple products, or a statement that
there are no changes to their previously
submitted ingredient report.
Respondents may submit the required
information to CDC through a
designated representative. The
information collection is subject to strict
confidentiality provisions.
Ingredient reports for new SLT
products are due at the time of first
importation. Thereafter, ingredient
reports are due annually on March 31.
Information is submitted to CDC by
mailing a written report on the
respondent’s letterhead, by CD, threeinch floppy disk, or thumb drive.
Electronic mail submissions are not
accepted. Annual submission reports
are mailed to Attention: FCLAA
Program Manager, Office on Smoking
and Health, National Center for Chronic
Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway
NE, MS S107–7, Atlanta, GA 30341–
3717.
Upon receipt and verification of the
annual nicotine and ingredient report,
CDC issues a Certificate of Compliance
to the respondent. As deemed
appropriate by the Secretary of HHS,
HHS is authorized to use the
information to report to Congress the
health effects of ingredients, research
activities related to the health effects of
ingredients, and other information that
the Secretary determines to be of public
interest. The estimated annual Burden
Hours are 18,843. There are no costs to
respondents other than their time. OMB
approval is requested for three years.
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Annual Submission of the Ingredients
Added to, and the Quantity of Nicotine
Contained in, Smokeless Tobacco
Manufactured, Imported, or Packaged in
the U. S.—Extension—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Smokeless tobacco products (SLT) are
associated with many health problems.
Using smokeless tobacco: Can lead to
nicotine addiction; causes cancer of the
mouth, esophagus, and pancreas; is
associated with diseases of the mouth;
can increase risks for early delivery and
stillbirth when used during pregnancy;
can cause nicotine poisoning in
children; and, may increase the risk for
death from heart disease and stroke.
The CDC’s Office on Smoking and
Health (OSH) has the primary
responsibility for the HHS smoking and
health program. As required by the
Comprehensive Smokeless Tobacco
Health Education Act of 1986 (CSTHEA,
15 U.S.C. 4401 et seq., Pub. L. 99–252),
CDC collects a list of ingredients added
to tobacco in the manufacture of
smokeless tobacco products and a
specification of the quantity of nicotine
contained in each product. HHS has
delegated responsibility for
implementing the required information
collection to CDC’s OSH. Respondents
are manufacturers, packagers, or
importers (or their representatives) of
smokeless tobacco products.
Respondents are not required to submit
specific forms; however, they are
required to meet reporting guidelines
and to submit the ingredient report by
chemical name and Chemical Abstract
amozie on DSK3GDR082PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Smokeless Tobacco Manufacturers,
Packagers, and Importers.
SLT Nicotine and Ingredient and
Report.
VerDate Sep<11>2014
16:34 Aug 21, 2018
Jkt 244001
PO 00000
Frm 00046
Fmt 4703
Sfmt 9990
Number of
responses per
respondent
11
E:\FR\FM\22AUN1.SGM
1
22AUN1
Average
burden per
response
(in hours)
1,713
Total
burden
(in hours)
18,843
Federal Register / Vol. 83, No. 163 / Wednesday, August 22, 2018 / Notices
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–18053 Filed 8–21–18; 8:45 am]
Family First Services Act
Title IV–E Planning Grants—What
barriers are preventing Tribes from
applying for the grant
Office of Head Start annual consultation
TANF and Welfare reform
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Administration for Native Americans;
Notice of Meeting
Administration for Children
and Families, Department of Health and
Human Services.
ACTION: Notice of Tribal Consultation.
AGENCY:
The Department of Health and
Human Services, Administration for
Children and Families (ACF) will host
a Tribal Consultation to consult on ACF
programs and tribal priorities.
DATES: September 13, 2018.
ADDRESSES: Capital Skyline Hotel, 10
‘‘I’’ (eye) Street SW, Washington, DC
20024.
FOR FURTHER INFORMATION CONTACT:
Jeannie Hovland, Commissioner,
Administration for Native Americans
and Deputy Assistant Secretary for
Native American Affairs at 202–401–
5156, by email at anacommissioner@
acf.hhs.gov or by mail at 330 C Street
SW, MS–4126, Washington, DC 20201.
SUPPLEMENTARY INFORMATION: In
accordance with the ACF Tribal
Consultation Policy, ACF announces
tribal consultation with tribal leaders
operating ACF programs.
The consultation will be conducted
with elected or appointed leaders of
tribal governments and their designated
representatives. Designees must have a
letter from the tribal government
authorizing them to represent the tribe.
Tribal governments must submit the
designee letter at least 3 days in advance
of the consultation session to the
Administration for Native Americans at
anacommissioner@acf.hhs.gov. Other
representatives of tribal organizations
and Native non-profit organizations are
welcome to attend as observers. A report
of the consultation session will be
prepared and made available at the
following website address within 45
days after the closing of the consultation
session. Tribes wishing to submit
written testimony should send it to
anacommissioner@acf.hhs.gov either
prior to the consultation session or
within 30 days after the meeting. ACF
amozie on DSK3GDR082PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:34 Aug 21, 2018
Jkt 244001
will summarize oral testimony and
comments from the consultation session
along with topics of concern and
recommendations.
ACF has identified the following
topics for consultation:
The ACF Tribal Consultation Session
will begin at 9:00 a.m. on September 13
and continue throughout the day until
all discussions have been completed. To
help both you and the ACF Principals
prepare for this consultation, planning
teleconference calls will be held:
Wednesday, August 22, 2018 @4:00
p.m.–4:30 p.m. (EST)
Thursday, August 23, 2018 @4:00 p.m.–
4:30 p.m. (EST)
Tuesday, August 28, 2018 @4:00 p.m.–
4:30 p.m. (EST)
The call-in number and passcode are:
866–769–9393 passcode: 4449449#.
The purpose of the planning calls will
be to identify individuals who will
provide oral testimony to ACF, solicit
for tribal moderators and identify
specific topics of interest so we can
ensure that all appropriate individuals
are present.
For any tribe unable to attend in
person, ACF will provide a webinar
link, Please contact our 1–877–922–
9ANA (1–877–922–9262) for the
webinar information.
We have set up a registration for all
participants whether attending in
person or by webinar. The registration
address is: www.regonline.com/
2018acftribalconsultation. If you plan
on providing testimony, please include
the name of the office(s) you wish to
address.
Jeannie Hovland,
Deputy Assistant Secretary for Native
American Affairs.
[FR Doc. 2018–18113 Filed 8–21–18; 8:45 am]
BILLING CODE 4184–34–P
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
42505
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Announcement of Intent To Issue one
OPDIV-Initiated Supplement to BCFS
Health and Human Services Under the
Standing Announcement for
Residential (Shelter) Services for
Unaccompanied Children, HHS–2017–
ACF–ORR–ZU–1132
Unaccompanied Alien
Children’s (UAC) Program, Office of
Refugee Resettlement (ORR),
Administration for Children and
Families (ACF), U.S Department of
Health and Human Services (HHS).
ACTION: Notice of intent to issue one
OPDIV-Initiated Supplement to BCFS
Health and Human Services, San
Antonio, TX under the UAC Program.
AGENCY:
ACF, ORR, announces the
intent to issue one OPDIV-Initiated
Supplement to BCFS Health and Human
Services, San Antonio, TX in the
amount of $28,003,926. ORR has been
identifying additional capacity to
provide shelter for potential increases in
apprehensions of Unaccompanied
Children at the U.S. Southern Border.
Planning for increased shelter capacity
is a prudent step to ensure that ORR is
able to meet its responsibility, by law,
to provide shelter for Unaccompanied
Alien Children referred to its care by the
Department of Homeland Security
(DHS). To ensure sufficient capacity to
provide shelter to unaccompanied
children referred to HHS, BCFS
proposed to provide ORR with 850 beds
in an expedited manner.
DATES: Supplemental award funds will
support activities through September
13, 2018.
FOR FURTHER INFORMATION CONTACT:
Jallyn Sualog, Director, Division of
Children’s Services, Office of Refugee
Resettlement, 330 C Street SW,
Washington, DC 20447. Phone: 202–
401–4997. Email: DCSProgram@
acf.hhs.gov.
SUPPLEMENTARY INFORMATION: ORR is
continuously monitoring its capacity to
shelter the unaccompanied children
referred to HHS, as well as the
information received from interagency
partners, to inform any future decisions
or actions.
ORR has specific requirements for the
provision of services. Award recipients
must have the infrastructure, licensing,
experience, and appropriate level of
trained staff to meet those requirements.
The expansion of the existing program
and its services through this
SUMMARY:
E:\FR\FM\22AUN1.SGM
22AUN1
]]>Agencies
[Federal Register Volume 83, Number 163 (Wednesday, August 22, 2018)]
[Notices]
[Pages 42503-42505]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-18053]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-18-0338; Docket No. CDC-2018-0076]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS)
ACTION: Notice with comment period
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed work
and/or continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a continuing
information collection project titled Annual Submission of the
Ingredients Added to, and the Quantity of Nicotine Contained in,
Smokeless Tobacco Manufactured, Imported, or Packaged in the U.S.
DATES: CDC must receive written comments on or before October 22, 2018.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0076 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and
[[Page 42504]]
instruments, contact Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-
3520), Federal agencies must obtain approval from the Office of
Management and Budget (OMB) for each collection of information they
conduct or sponsor. In addition, the PRA also requires Federal agencies
to provide a 60-day notice in the Federal Register concerning each
proposed collection of information, including each new proposed
collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Annual Submission of the Ingredients Added to, and the Quantity of
Nicotine Contained in, Smokeless Tobacco Manufactured, Imported, or
Packaged in the U. S.--Extension--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Smokeless tobacco products (SLT) are associated with many health
problems. Using smokeless tobacco: Can lead to nicotine addiction;
causes cancer of the mouth, esophagus, and pancreas; is associated with
diseases of the mouth; can increase risks for early delivery and
stillbirth when used during pregnancy; can cause nicotine poisoning in
children; and, may increase the risk for death from heart disease and
stroke.
The CDC's Office on Smoking and Health (OSH) has the primary
responsibility for the HHS smoking and health program. As required by
the Comprehensive Smokeless Tobacco Health Education Act of 1986
(CSTHEA, 15 U.S.C. 4401 et seq., Pub. L. 99-252), CDC collects a list
of ingredients added to tobacco in the manufacture of smokeless tobacco
products and a specification of the quantity of nicotine contained in
each product. HHS has delegated responsibility for implementing the
required information collection to CDC's OSH. Respondents are
manufacturers, packagers, or importers (or their representatives) of
smokeless tobacco products. Respondents are not required to submit
specific forms; however, they are required to meet reporting guidelines
and to submit the ingredient report by chemical name and Chemical
Abstract Service (CAS) Registration Number, consistent with accepted
reporting practices for other companies that are required to report
ingredients added to other consumer products. Typically, respondents
submit a summary report to CDC with the ingredient information for
multiple products, or a statement that there are no changes to their
previously submitted ingredient report. Respondents may submit the
required information to CDC through a designated representative. The
information collection is subject to strict confidentiality provisions.
Ingredient reports for new SLT products are due at the time of
first importation. Thereafter, ingredient reports are due annually on
March 31. Information is submitted to CDC by mailing a written report
on the respondent's letterhead, by CD, three-inch floppy disk, or thumb
drive. Electronic mail submissions are not accepted. Annual submission
reports are mailed to Attention: FCLAA Program Manager, Office on
Smoking and Health, National Center for Chronic Disease Prevention and
Health Promotion, Centers for Disease Control and Prevention, 4770
Buford Highway NE, MS S107-7, Atlanta, GA 30341-3717.
Upon receipt and verification of the annual nicotine and ingredient
report, CDC issues a Certificate of Compliance to the respondent. As
deemed appropriate by the Secretary of HHS, HHS is authorized to use
the information to report to Congress the health effects of
ingredients, research activities related to the health effects of
ingredients, and other information that the Secretary determines to be
of public interest. The estimated annual Burden Hours are 18,843. There
are no costs to respondents other than their time. OMB approval is
requested for three years.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Smokeless Tobacco SLT Nicotine and 11 1 1,713 18,843
Manufacturers, Packagers, and Ingredient and
Importers. Report.
----------------------------------------------------------------------------------------------------------------
[[Page 42505]]
Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-18053 Filed 8-21-18; 8:45 am]
BILLING CODE 4163-18-P
